奥精医疗科技股份有限公司 关于选举第三届董事会职工代表董事的公告

Core Viewpoint - The announcement details the election of the third board of directors for Aojing Medical Technology Co., Ltd., including the appointment of a staff representative director and the restructuring of the board and management team [1][5][6]. Board Election and Restructuring - Aojing Medical held its third extraordinary general meeting on November 26, 2025, where the election of the third board of directors was approved, consisting of 9 directors, including 1 staff representative director [1][6]. - Helen Han Cui was elected as the staff representative director during the first staff representative assembly on November 26, 2025 [1][2]. - The newly elected board includes 5 non-independent directors and 3 independent directors, with a term of three years [1][8]. Management Appointments - The first meeting of the third board of directors approved the election of Huang Wanlan as the chairman and appointed new senior management, including Qiu Zhiye as the general manager and Tian Guofeng and Song Tianxi as deputy general managers [7][10]. - Wang Ling was appointed as the financial officer and also serves as the board secretary [10][14]. Legal Compliance and Qualifications - All elected directors and appointed senior management meet the qualifications set forth by the Company Law and the company's articles of association, with no disqualifications reported [4][11][15]. - The company has canceled its supervisory board, transferring its responsibilities to the audit committee of the board [12][13]. Shareholder Meeting and Voting - The extraordinary general meeting was conducted in compliance with legal requirements, with no resolutions being rejected [16][23]. - The voting process included both on-site and online participation, ensuring transparency and adherence to regulations [16][18].